Neurodegenerative Disorder Management

External Event - 18th May 2017


This one day meeting with top specialists in neurology will present on the rarer neurodegenerative disorders including, multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Book now to hear the future management and research for improving the lives of patients.

The event takes play on Thursday 18th May 2017 at the Royal Society of Medicine in London. 


Professor Gregor Wenning, Department of Neurology, Innsbruck Medical University, Germany
Best known for his clinical and scientific work in Parkinson's disease and atypical Parkinsonian disorders, particularly multiple system atrophy (MSA)

Professor Niall Quinn, Emeritus Professor of Clinical Neurology, University College London
Specialised in movement disorders for the last 40 years, and has a particular interest in MSA

Professor James Rowe, Consultant Neurologist, Cambridge University Hospitals NHS Foundation Trust
Lead of clinical services for disorders of movement and cognition, including PSP and CBD 


Know about developments in the understanding of the genetic and molecular basis of neurodegenerative disorders

Know about the most affective approaches in palliative care

Understand current views of the epidemiology in PSP and CBD

Appreciate the impact of a multi-professional team including the role of MSA nurse specialists and therapists in neurodegenerative disorders

Understand current pharmacological management and symptom control


RSM member rates £5 - £20

Non member rates £10 - £50

Online registration will close on Monday 15 May
*Tickets include tea, coffee and lunch

More information and registration can be found by clicking here






< Back to Events